Related Experiment Video
Updated: Jun 23, 2026

Characterizing Modulators of Protease-Activated Receptors with a Calcium Mobilization Assay Using a Plate Reader
Published on: May 24, 2024
Compounds binding to the S2-S3 pockets of thrombin
Mikael Nilsson1, Markku Hämäläinen, Maria Ivarsson
1School of Pure and Applied Natural Sciences, University of Kalmar, S-391 82 Kalmar, Sweden. Mikael.Nilsson@hik.se
Researchers designed compounds targeting thrombin
Area of Science:
- Medicinal Chemistry
- Biochemistry
- Structural Biology
Background:
- Thrombin is a key enzyme in blood coagulation.
- Targeting thrombin's S2-S3 pockets offers a strategy for inhibitor design.
- Understanding ligand interactions with serine protease pockets is crucial.
Purpose of the Study:
- To design and synthesize novel thrombin inhibitors targeting the S2-S3 pockets.
- To investigate the impact of P1 substituents and hydrogen bonding on binding affinity.
- To elucidate the binding mode and guide future drug discovery efforts.
Main Methods:
- Synthesis of diverse compound libraries.
- Surface Plasmon Resonance (SPR) biosensor technology for binding constant determination.
- Enzyme assays for validating binding affinities.
- X-ray crystallography for structural analysis.
- Quantitative Structure-Activity Relationship (QSAR) modeling.
Main Results:
- Compounds with an amino group showed a 100-1000 fold increase in binding affinity due to hydrogen bonding with Gly216.
- Increased ligand efficiency was achieved through hydrophobic interactions in the P1 pocket.
- X-ray analysis confirmed the predicted binding mode, including hydrogen bonds and a bound water molecule.
- QSAR models highlighted the importance of hydrogen bonding and lipophilicity for binding constants.
Conclusions:
- Hydrogen bonding interactions, particularly with Gly216, significantly enhance thrombin inhibitor potency.
- Optimizing hydrophobic interactions in the P1 pocket improves ligand efficiency.
- Structural and QSAR data provide a foundation for designing targeted compound libraries for shallow protease pockets.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
Drug Binding to Blood Components
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
Venous Thrombosis I: Introduction
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...

